News & Press
Somnoware announced today that the company is partnering with Cerebra Medical to integrate Cerebra’s autoscoring technology, MY Autoscoring, into the Somnoware platform. This partnership will enable automated sleep study scoring directly within the Somnoware platform. To learn more about this partnership, view the press release here
Home grown technology supporting pandemic recovery January 17, 2023: Winnipeg, Manitoba. Cerebra, a Winnipeg based medical technology company advancing sleep disorder diagnostics, has entered into a contract with The Government of Manitoba under a Request for Supply Arrangement (RFSA) for the Provision of Diagnostic Services. Through the arrangement, Cerebra will work closely with the Province…
Winnipeg, Canada — Cerebra Medical Ltd., a Canadian technology company transforming the future of sleep disorder diagnosis and therapy, announced today it has received 510(k) market clearance from the US Food and Drug Administration (FDA) for its Cerebra Sleep System; a lab quality in-home polysomnography (PSG) that is fully self-applied by the patient, without the…
Ekosi Health, a Canadian Indigenous-owned health care provider with expertise in clinical cannabinoid therapy has partnered with Cerebra, a Winnipeg based MedTech start-up revolutionizing sleep disorder diagnosis to advance the science of cannabinoid therapy and sleep. While there is promising preliminary evidence on the positive impact of cannabinoid therapies for sleep improvement, results to date…
First of its kind sleep measurement tool to help simplify diagnostic process for physicians Innovative research from leading sleep scientists Dr. Magdy Younes and associates using novel EEG metric Odds Ratio Product (ORP) as a measure of sleep quality has revealed new insights into clinical symptoms of sleep disorders not detected through conventional metrics.…
Team of leading sleep scientists win the American Academy of Sleep Medicine award by using advanced sleep analytics based on ORP June 15, 2021: Winnipeg, Manitoba. A team of leading sleep scientists led by Dr. Amy Bender of Cerebra Health (Cerebra), a leader in sleep science, has won the inaugural American Academy of Sleep…
New leadership advances Cerebra’s mission to transform the future of sleep diagnosis and therapy, globally Brian Hayward, Board Chair of Cerebra, a leader in sleep science, today announces the appointment of Nicholas Kosciolek to the role of CEO. Kosciolek brings international leadership and a proven track record for driving profitable growth in MedTech start up…
To learn more about this award, view the Press Release Here.
Harvard Medical School research uses Cerebra’s Odds Ratio Product (ORP), the first highly validated measure of sleep depth, to predict driving safety in patients suffering from obstructive sleep apnea. Two research studies demonstrate how Cerebra’s sleep depth measure, Odd Ratio Product (ORP), is enabling new discoveries in sleep, sleep issues, and sleep care. Researchers…
Committee members will support Cerebra in its mission to change the future of sleep diagnosis and therapy January 12, 2021: Winnipeg, Manitoba. Cerebra, a leader in sleep science, today announces the formation of a Scientific Advisory Board in support of its mission to transform the diagnosis and treatment of major sleep disorders. Cerebra digital sleep…